Publications
Lessons from a Pandemic: Maintaining Compliant GxP Surveillance Programs and Stable Pharmaceutical Supply
COVID-19 impact on global pharmaceutical supply chain management
Co-authored with Jose Caraballo of Bayer Pharmaceuticals
Rise of Virtual/Remote work article in PDA Letter
Case studies including COVID-19 project execution
Unprecedented global phenomenon
Co-authored with Ali Ardakani of Novateur Ventures
QA Compliance & GPP's in Cannabis Industry
Keystone Laboratories conference series
Speaking engagement in partnership with QnR Associates
Final Agenda Preparing Your Cannabis Facility for Success.pdfForeign Manufacturing Sites
Challenges with foreign sites in NHP industry
Foreign Sites article -Contact Canada 2008.pdfQA Agreements in Health Regulated Industries
Vital importance of good QA Agreements
rock solid QA agreements article.pdfGEN Article
Contributing writer for numerous articles
Fenton Fong GEN Apr15-07.pdfGenetic Engineering News articles published
1. “Artificial Tissues Target Range of Medical Conditions”, Vol.20, No. 1 Jan 2000.
2. “Challenges in Pharmacogenomics”, Vol.20, No.6 Mar 15, 2000.
3. “Animal Cloning Techniques and Technologies”, Vol.21, No.1, Jan 1, 2001.
4. “Rational Drug Design in the Post-Genomics Era”, Vol.21, No. 20, Nov 15, 2001.
5. “Contract Bio-Product Stability Testing Services”, Vol. 23, No. 6 Mar 15, 2003.
6. “Recombinant protein product production in animal species”, 2003.
7. Structure-based Drug Design, 2004
8. “Techniques in Viral Clearance Validation”, 2005.
9. Corporate Profile: “Progenitor Tackles Obstacles in Cell Therapy”, vol.25, No. 17, Oct 1 2005.
10. “Techniques for Characterizing Biologics”, Apr-May 2007 -see above for copy